Iaso Therapeutics
PrivateLast Round
Seed
Jan 25, 2023
Total Funding Raised
$2.84M
Company Overview
Iaso Therapeutics, Inc. is a biotechnology company that spun out from Michigan State University in 2018. The company is focused on developing next-generation vaccines to treat a variety of diseases, including cancer and infectious diseases. It utilizes a proprietary mutant bacteriophage Qβ (mQβ) platform technology, which has shown the ability to elicit more powerful immune responses compared to benchmark carriers. Iaso Therapeutics aims to translate this cutting-edge technology, developed in the laboratory of founder Dr. Xuefei Huang, to promote human health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iaso Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Iaso Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 25, 2023 | ||||
| Grant | Mar 14, 2022 | ||||
| Grant | Jul 15, 2021 | ||||
| Pre Seed | May 31, 2021 |
Iaso Therapeutics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Will present at the 2026 World Vaccine Congress on March 31, 2026.
Iaso Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Iaso Therapeutics's valuation, stock price, and market status.
